Navigation Links
Outcomes Pharmaceutical Health Care(r) Becomes an ASCP MTM Provider Partner
Date:11/20/2007

PHILADELPHIA, Nov. 20 /PRNewswire-USNewswire/ -- The American Society of Consultant Pharmacists (ASCP) announces that Outcomes Pharmaceutical Health Care(r) (Outcomes(r)) has become one of ASCP's Medication Therapy Management (MTM) Provider Partners. This announcement was made today at Senior Care Pharmacy '07 -- ASCP's 38th Annual Meeting and Exhibition taking place in Philadelphia.

The need for skilled clinicians to deliver MTM services has increased dramatically since the coverage of MTM services under Medicare Part D, especially for patients residing outside of nursing facilities. ASCP's MTM Provider Partners, recognizing the excellence of ASCP members, turned to the Society to help them enlist consultant and senior care pharmacists to deliver MTM services to their contracted enrollees.

Consultant and senior care pharmacists are clinicians specially trained in geriatric pharmacotherapy who review patients' medication regimens to ensure they are receiving the most appropriate, safe, and most effective medications, and that they are used appropriately. Further, consultant and senior care pharmacists identify individuals at high risk for medication-related problems, and identify and resolve health problems that are not otherwise recognized as medication-related.

"This new partnership will expand the reach of ASCP member consultant and senior care pharmacists into community-based settings, bringing much needed clinical expertise to medically complex patients wherever they reside," said ASCP Executive Director & CEO John Feather.

Since 1999, Outcomes has specialized in delivering MTM services to patients covered under employer sponsored health benefits, Medicare Part D plans, Medicaid programs, health plans, union funds, pharmacy benefits managers, disease management firms, case management companies, and various managed care organizations.

"Across the nation, more than two million patients are eligible for Outcomes MTM progra
'/>"/>

SOURCE American Society of Consultant Pharmacists
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Comparison of obstetric outcomes between on-call and patients own obstetricians
2. Continued Statin Use Boosts Post-Stroke Outcomes
3. inVentiv Health Launches Fourth Business Segment: inVentiv Patient Outcomes
4. QI projects may -- or may not -- improve patient safety and outcomes
5. Hospitals Could Improve Outcomes for Patients and Save Millions According to Hill-Rom 10th Annual Pressure Ulcer Survey
6. Bypass Off-Pump Boosts Womens Outcomes
7. Mayo Clinic study indicates medication for ADHD may help student outcomes
8. Experts Compare Colon Cancer Treatment Outcomes
9. Gene Chip Data Can Boost Cancer Outcomes
10. Eclipsys Knowledge-Based Charting Helps Health First Improve Patient-Care Outcomes
11. Studies suggest key correlation between lung cancer subtype and treatment outcomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...CAGO, Jan. 8 Allscripts-...ipts Healthcare Solutions, Inc. (Allscripts or,th...for the three and six,months ended November 30, 2...in/prnh/20061005/ALLSCRIPTSLOGO-b ) , The C...d November 30, 2008,include results from legacy A...
(Date:1/8/2009)...TON, Jan. 8 The Pew Cha...has been named director, chemical and food safety ...y program. Olson, who was formerly deputy staff di... on Environment and Public Works, brings nearly 25...onsumer advocacy to Pew. , , "We are excited t...
(Date:1/8/2009)...une Promoted to Principal. Christine Siu and Jaso...INNEAPOLIS, SAN FRANCISCO and STAMFORD, Conn., Jan...s, a health care venture capital firm that invests... today announced the promotion of three members of...d to Principal. Christine Siu and Jason Brown hav...
(Date:1/8/2009)...POLIS, Jan. 8 A proposa...diers and Sailors Children,s Home has prompted the...ana to revamp its annual Mid-Winter conference Jan...ate its members, nearly unanimous opposition to th...ides more than $50,000 in direct and in-kind suppo...
Breaking Medicine News(10 mins):Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 2Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 3Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 4Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 5Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 6Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 7Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 8Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 9Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 10Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 11Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 12Health News:Allscripts Reports Fiscal 2009 Second Quarter Results 13Health News:Veteran Environmental Health Expert Erik D. Olson to Join Pew 2Health News:Thomas, McNerney & Partners Promotes Three Members of Its Investment Team 2
...ers in a recent study on both mice and humans are ...to their body than others. Did you know that if yo..., say, //or a doughnut - the amount of cholesterol... Experts know that high cholesterol is linked to h...
...study are trying to observe why surgery may trigg...re ongoing. It's long been known that some older p...l functions after an operation// - a condition kno....Often relatives will say that the person has 'nev...
...ers it is observed that a drug already being used ...fective male contraceptive. Researchers hypothesiz...een approved in Europe to treat Gaucher's disease,...affects the metabolism of sugar-fat compounds esse...
...y, a protein in the eye has prevented and stopped ...earchers say this could lead to promising treatmen...e sclerosis and type 1 diabetes. Scientists from t...Boston found the factor alpha-MSH can be harnessed...
Other Medicine News:
(Date:1/6/2009)...ts from prior U.S., U.K. and China Trials , , S...Inc. (VTI), a development stage company targeting ...has begun for a randomized, controlled, multi-cent...racorporeal Liver Assist Device (ELAD) as a treatm...der three protocols. The study is open for enrollm...
(Date:1/6/2009)...e/ -- Cequent Pharmaceuticals, a pioneer in the de...treatments to prevent and treat human disease, ann...uccessful toxicology study of its candidate CEQ501...eting the primary oncogene (beta-catenin, CTNNB1) ... inherited gastrointestinal disease that causes hu...
(Date:1/5/2009)...swire/ -- Women undergoing in vitro,fertilization...port early,pregnancy, but the intramuscular injec...inful for patients. Formulations of progesterone ...ous injection or vaginal suppository may offer,si... With patient well-being a constant focus, Fert...
(Date:12/27/2008)...ewswire/ -- According to the latest,science, resv...est doses of,resveratrol plus an array of antioxi...asses of aged, red wine, rather than resveratrol a...i-bin/prnh/20080603/LATU039 ) , The most r...s to prolong,the life of laboratory mice. In fac...
Breaking Medicine Technology:ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 2ELAD(R) Liver Support System Study Initiated at Multiple U.S. Centers 3Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 2Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference 3Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 2Longevity Seekers Advised to Consume Modest Doses of Red Wine Molecules in Dietary Supplements (Longevinex(R)) Rather than Mega-Dose Resveratrol Alone 3IMTEC Introduces the SPRITE CT System 21584 1IMTEC Introduces the SPRITE CT System 21584 2HMS Holdings Corp to Present at Jefferies 2nd Annual Healthcare Conference 21582 1COSE Introduces Health Incentives Wellness Programs for Medium Size Businesses 21580 1COSE Introduces Health Incentives Wellness Programs for Medium Size Businesses 21580 2Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 1Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 2Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 3Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 4Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates 5939 5
...gression-free survival in,the SPARC Phase 3 trial ...isk of disease progression for patients receiving,...e use,geographies, as well as presence or absence...tCall/ -- Pharmion,Corporation and GPC Biotech AG ...a from the double-blind, randomized satraplatin Ph...
...ts EORTC 40983 (EPOC),Intergroup Study Results, CH...ults of the,randomized phase III EORTC 40983 Inter...rst time that peri-operative (pre and post,surgery...combination with a standard chemotherapy regimen f...V)) given to patients with,resectable liver metast...
Other Medicine Technology:Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 2Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 3Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 4Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 5Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 6Additional New Data from Satraplatin SPARC Phase 3 Investigational,Trial Presented at ASCO Annual Meeting 7The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 2The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 3The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 4The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 5The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 6The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 7The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 8The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved,Progression Free Survival When Given Before and After Surgery in,Patients With Resectable Liver Metastases From Colorectal Cancer 9
The herbal extracts, vitamins, minerals, and antioxidants in this formula increases circulation to ocular tissue, improves tear quality, and maintains healthy function of the lens and retina of the e
...-Rads QCNet is the industry-leading portal to QC i... easy and rapid way to access their quality contro...ternet. UnityWeb enables Bio-Rad customers to acce...boratory Reports, as well as convenient online dat...
The ACCU-CHEK Spirit insulin pump system offers frequent and precise delivery of the basal rate and rapid infusion of the bolus. The ACCU-CHEK Spirit pump is safe, reliable and easy to program.
The MiniMed Paradigm REAL-Time System is the world's first system to integrate an insulin pump with REAL-Time continuous glucose monitoring, taking diabetes management to a level you just can't achie
Medicine Products: